Rare disease biotech Rallybio cuts 19 staffers and sheds partnered preclinical programs
Rallybio is laying off close to half of its employees and seeking “alternative options” for its preclinical programs as it gets …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
